As cells age, their telomeres naturally shorten, eventually reaching a point where cells can no longer divide. This cellular aging is artificially accelerated during ex-vivo manufacturing of cell and gene therapies. Telos's mission is to overcome these limitations by safely lengthening telomeres, thus boosting the efficacy of cell therapies.
Telovance™ is a protein complex that is delivered inside the cells during the process of cell therapy manufacturing to prevent the rapid shortening of cellular telomeres. This will help create a more robust and effective cell therapy product. Telovance™ is designed to seamlessly integrate into current and next gen cell manufacturing processes

At Telos Biotechnology, our most compelling point of traction is Telovance™, a proprietary protein complex designed to transform the cell and gene therapy landscape.

1. Breakthrough Technology: Telovance™
Telovance™ is a novel ancillary reagent that can be seamlessly integrated into both current and next-generation cell manufacturing processes. By preventing the rapid shortening of telomeres during ex vivo expansion, Telovance™ helps generate more robust, durable, and effective cell therapy products.

2. Broad Applicability Across Therapeutic Areas
The versatility of Telovance™ positions it as a platform-enabling solution with applications spanning:
- Cancer immunotherapy (e.g., CAR-T and beyond) – enhancing persistence and potency of engineered immune cells.
- Autoimmune diseases – improving the durability of engineered regulatory immune cells.
- Regenerative medicine – extending the functional lifespan of therapeutic cell populations.
- Longevity and anti-aging – opening the door to rejuvenation strategies that improve cellular health.

3. Seamless Market Integration
Unlike therapies requiring entirely new platforms, Telovance™ is designed as an ancillary reagent—a plug-and-play technology that can be adopted by a wide range of cell and gene therapy developers without disrupting their existing workflows. This dramatically lowers barriers to adoption while expanding its impact across multiple verticals.

4. Strategic Positioning in a High-Growth Market
With the global cell and gene therapy market rapidly expanding, Telovance™ offers a unique, enabling technology that addresses a core limitation—telomere-driven cell exhaustion. This positions Telos Biotechnology not just as a therapy developer, but as a critical partner powering the next generation of curative treatments.